Historical Valuation
Jaguar Health Inc (JAGX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.27 is considered Fairly compared with the five-year average of -2.11. The fair price of Jaguar Health Inc (JAGX) is between 0.70 to 1.71 according to relative valuation methord.
Relative Value
Fair Zone
0.70-1.71
Current Price：1.05
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Jaguar Health Inc (JAGX) has a current Price-to-Book (P/B) ratio of 1.17. Compared to its 3-year average P/B ratio of 0.97 , the current P/B ratio is approximately 21.22% higher. Relative to its 5-year average P/B ratio of 3.02, the current P/B ratio is about -61.29% higher. Jaguar Health Inc (JAGX) has a Forward Free Cash Flow (FCF) yield of approximately -576.21%. Compared to its 3-year average FCF yield of -442.83%, the current FCF yield is approximately 30.12% lower. Relative to its 5-year average FCF yield of -297.99% , the current FCF yield is about 93.36% lower.
P/B
Median3y
0.97
Median5y
3.02
FCF Yield
Median3y
-442.83
Median5y
-297.99
Competitors Valuation Multiple
AI Analysis for JAGX
The average P/S ratio for JAGX competitors is 0.04, providing a benchmark for relative valuation. Jaguar Health Inc Corp (JAGX.O) exhibits a P/S ratio of 0.27, which is 500% above the industry average. Given its robust revenue growth of -0.80%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for JAGX
1Y
3Y
5Y
Market capitalization of JAGX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of JAGX in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is JAGX currently overvalued or undervalued?
Jaguar Health Inc (JAGX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.27 is considered Fairly compared with the five-year average of -2.11. The fair price of Jaguar Health Inc (JAGX) is between 0.70 to 1.71 according to relative valuation methord.
What is Jaguar Health Inc (JAGX) fair value?
JAGX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Jaguar Health Inc (JAGX) is between 0.70 to 1.71 according to relative valuation methord.
How does JAGX's valuation metrics compare to the industry average?
The average P/S ratio for JAGX's competitors is 0.04, providing a benchmark for relative valuation. Jaguar Health Inc Corp (JAGX) exhibits a P/S ratio of 0.27, which is 500.00% above the industry average. Given its robust revenue growth of -0.80%, this premium appears unsustainable.
What is the current P/B ratio for Jaguar Health Inc (JAGX) as of Jan 10 2026?
As of Jan 10 2026, Jaguar Health Inc (JAGX) has a P/B ratio of 1.17. This indicates that the market values JAGX at 1.17 times its book value.
What is the current FCF Yield for Jaguar Health Inc (JAGX) as of Jan 10 2026?
As of Jan 10 2026, Jaguar Health Inc (JAGX) has a FCF Yield of -576.21%. This means that for every dollar of Jaguar Health Inc’s market capitalization, the company generates -576.21 cents in free cash flow.
What is the current Forward P/E ratio for Jaguar Health Inc (JAGX) as of Jan 10 2026?
As of Jan 10 2026, Jaguar Health Inc (JAGX) has a Forward P/E ratio of -0.11. This means the market is willing to pay $-0.11 for every dollar of Jaguar Health Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Jaguar Health Inc (JAGX) as of Jan 10 2026?
As of Jan 10 2026, Jaguar Health Inc (JAGX) has a Forward P/S ratio of 0.27. This means the market is valuing JAGX at $0.27 for every dollar of expected revenue over the next 12 months.